Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : SNYNF    crawled time : 01:00    save search

Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.09% C: -0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 0.5% C: 0.11%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 0.01% C: -1.45%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.0% C: 0.0%

report research global
Janus Kinase (JAK) Inhibitors Global Market Report 2024, Featuring Key Players Pfizer, Merck, AbbVie, Novartis, Sanofi, Bristol Myers Squibb, GSK, Takeda, Eli Lilly and Gilead Sciences
Published: 2024-03-05 (Crawled : 01:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.22% C: -0.2%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.24% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.17% H: 0.0% C: 0.0%

report sciences global key market
Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market Analysis Report 2024: A $133.5 Billion in 2030 Featuring Eli Lilly and Co, Pfizer, Sanofi, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: -1.72% H: 2.54% C: 2.54%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -2.2% H: 2.39% C: 1.34%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.79% C: 0.6%

report agonist global market
North America and Europe Bus ADAS Market Analysis and Growth Opportunities, 2022-2024 and Forecasts to 2030: Coach Buses to Incorporate Significant ADAS Features while Transit Buses Move Toward Autonomy
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%

america europe bus growth coach market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 1.12% C: 0.43%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $63.676 -4.38% 7.2K twitter stocktwits trandingview |
Manufacturing
| | O: 1.46% H: 0.44% C: 0.44%
ALPMY | $9.47 -1.11% 520K twitter stocktwits trandingview |
Manufacturing
| | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.24 0.61% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 0.14% C: -0.48%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 1.63% C: 1.48%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 2.08% C: 1.38%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 1.15% C: 0.96%

lung reach cancer cell diagnostics therapy market
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA
Published: 2024-02-20 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 2.72% H: 0.0% C: -0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.53% H: 0.0% C: 0.0%

ibi311 disease thyroid eye trial
Global Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report 2023-2030
Published: 2024-02-13 (Crawled : 01:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.7% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%

report global trends therapeutics market
Global Biopharmaceutical Fermentation Market Analysis Report 2023-2028: Expanding Biosimilars Market, Continuous Fermentation Processes, and Growing Pipeline of Biopharmaceuticals Bolster Growth
Published: 2023-12-15 (Crawled : 01:00) - prnewswire.com
LZAGF | $563.5 -19.1% 6 twitter stocktwits trandingview |
Health Technology
| | O: 4.1% H: 0.31% C: -1.9%
LZAGY | $55.65 0.02% 32K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 3.28% H: 0.46% C: -0.61%
TMO | News | $544.78 0.6% 0.0% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.41% H: 0.0% C: 0.0%
DHR | $235.51 -0.36% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 0.05% C: -1.11%
BDX | $234.12 0.42% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.8% H: 1.46% C: 1.19%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.93% H: 0.0% C: 0.0%

report pipeline global growing growth market
Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 1.67% C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.15% H: 0.0% C: 0.0%
REGN | $896.27 0.26% 0.25% 500K twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 1.35% C: 1.19%


Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alone
Published: 2023-12-11 (Crawled : 01:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 1.67% C: 0.1%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.15% H: 0.0% C: 0.0%

sarclisa disease plus
Global Bioreactors Market Forecast Report 2023-2033: Influence of Single-use Technologies on Market Direction
Published: 2023-12-08 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 2.06% H: 0.82% C: 0.82%
TMO | News | $544.78 0.6% 0.0% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 0.0% C: 0.0%
DHR | $235.51 -0.36% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.46% C: -0.69%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.07% H: 0.0% C: 0.0%

report global market
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
Published: 2023-12-07 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -1.66% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.0% C: 0.0%

positive ongoing collaboration study
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.77% H: 0.49% C: 0.49%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.2% H: 1.7% C: 1.3%

rient-16 treatment results study
Drugs For Benign Prostatic Hypertrophy Market Report 2024 - Market to Reach $5.45 billion in 2028 - Opportunities in Minimally Invasive Treatments, Personalized Medicine and Combination Therapies
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.77% H: 0.49% C: 0.49%
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.0% C: 0.0%
VERU | $1.305 -8.1% -8.81% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 14.29% C: 13.27%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.0% C: 0.0%

report reach market
China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
Published: 2023-11-24 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 1.66% C: 1.66%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.37% C: 0.3%

ibi351 drug granted review designation medical application china
Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 0.94% H: 2.55% C: 2.55%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: 2.52% H: 0.04% C: 0.04%
NVO | News | $122.71 -0.03% 0.17% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 0.73% C: 0.28%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.7% C: 0.57%
GSK | News | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.06% H: 1.9% C: 0.96%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

expected reach global dna medical technology market
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published: 2023-10-27 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -18.18% H: 0.0% C: 0.0%
NVSEF | $93.6375 6.88% 82K twitter stocktwits trandingview |
Health Technology
| | O: -3.68% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.17% C: -2.45%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 0.08% C: -1.92%
BHC | $8.69 1.05% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.15% C: -1.79%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -15.73% H: 0.0% C: 0.0%
BCLI A | $0.5384 4.69% 4.48% 1M twitter stocktwits trandingview |
Health Technology
| | O: 3.73% H: 1.8% C: -4.19%
BIIB | $194.39 2.03% 1.99% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.45% H: 0.12% C: -2.28%

propel disease research therapeutics growth market
Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS A | $11.25 1.17% 1.16% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.45% H: 2.46% C: 1.67%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 1.02% C: 0.4%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.77% H: 0.0% C: 0.0%

reach research market
Global Alport Syndrome Treatment Market Set to Surge, Projected to Reach USD 19.00 Million by 2032
Published: 2023-08-31 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.66% H: 0.0% C: 0.0%

reach treatment global set market
Empowering Healthcare: Global Vaccine Management System Market to Reach $441.17 million by 2028
Published: 2023-08-30 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -1.57% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800 twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.0% C: -2.26%
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.25% H: 0.47% C: -1.08%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 0.27% C: -0.59%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.66% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.17% C: -0.86%

management vaccine reach global system market
Gainers vs Losers
67% 33%

Top 10 Gainers
JOE 4 | $54.88 1.22% 0.22% 210K twitter stocktwits trandingview |
Finance

JBI 4 | $15.14 1.34% 0.0% 2.9M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.